Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hansi J Dean

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|September 18, 2014
Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccinesGenevieve Clutton, Alexei Carpov, Christopher L Parks, et al.
Vaccine|March 20, 2016
Status of vaccine research and development of vaccines for HIV-1Jeffrey T Safrit, Patricia E Fast, Lisa Gieber, et al.
Vaccine|September 10, 2005
Epidermal DNA vaccine for influenza is immunogenic in humansRobert J Drape, Michael D Macklin, Lori J Barr, et al.
The Journal of Infectious Diseases|June 24, 2020
Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue VaccineDaniela Michlmayr, Paulina Andrade, Eduardo J M Nascimento, et al.
Biology Methods & Protocols|February 28, 2024
Identification and quantitation of multiple variants in RNA virus genomesJohnny Sena, Lovkesh Karwal, Callum Bell, et al.
Cell Reports|December 14, 2022
Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccinesNagarajan Raju, Xiaoyan Zhan, Subash Das, et al.
Plos One|April 23, 2021
A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple speciesKelly Bohning, Stephanie Sonnberg, Hui-Ling Chen, et al.
Vaccine|May 2, 2022
TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic miceKanami Tamura, Mai Kohnoe, Ayako Takashino, et al.
Vaccine|January 26, 2022
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic settingVianney Tricou, Raphael Gottardo, Michael A Egan, et al.
The Journal of Infectious Diseases|December 3, 2022
Antibodies Produced in Response to a Live-Attenuated Dengue Vaccine Are Functional in Activating the Complement SystemEduardo J M Nascimento, Brooke Norwood, Eloi Kpamegan, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|September 18, 2014
Optimizing parallel induction of HIV type 1-specific antibody and T-cell responses by multicomponent subunit vaccinesGenevieve Clutton, Alexei Carpov, Christopher L Parks, et al.
Vaccine|March 20, 2016
Status of vaccine research and development of vaccines for HIV-1Jeffrey T Safrit, Patricia E Fast, Lisa Gieber, et al.
Vaccine|September 10, 2005
Epidermal DNA vaccine for influenza is immunogenic in humansRobert J Drape, Michael D Macklin, Lori J Barr, et al.
The Journal of Infectious Diseases|June 24, 2020
Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue VaccineDaniela Michlmayr, Paulina Andrade, Eduardo J M Nascimento, et al.
Biology Methods & Protocols|February 28, 2024
Identification and quantitation of multiple variants in RNA virus genomesJohnny Sena, Lovkesh Karwal, Callum Bell, et al.
Cell Reports|December 14, 2022
Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccinesNagarajan Raju, Xiaoyan Zhan, Subash Das, et al.
Plos One|April 23, 2021
A high throughput reporter virus particle microneutralization assay for quantitation of Zika virus neutralizing antibodies in multiple speciesKelly Bohning, Stephanie Sonnberg, Hui-Ling Chen, et al.
Vaccine|May 2, 2022
TAK - 021, an inactivated Enterovirus 71 vaccine candidate, provides cross-protection against heterologous sub-genogroups in human scavenger receptor B2 transgenic miceKanami Tamura, Mai Kohnoe, Ayako Takashino, et al.
Vaccine|January 26, 2022
Characterization of the cell-mediated immune response to Takeda's live-attenuated tetravalent dengue vaccine in adolescents participating in a phase 2 randomized controlled trial conducted in a dengue-endemic settingVianney Tricou, Raphael Gottardo, Michael A Egan, et al.
The Journal of Infectious Diseases|December 3, 2022
Antibodies Produced in Response to a Live-Attenuated Dengue Vaccine Are Functional in Activating the Complement SystemEduardo J M Nascimento, Brooke Norwood, Eloi Kpamegan, et al.
Pageof 3